197 related articles for article (PubMed ID: 19648005)
1. Identification of small molecule inhibitors of proline-rich tyrosine kinase 2 (Pyk2) with osteogenic activity in osteoblast cells.
Allen JG; Lee MR; Han CY; Scherrer J; Flynn S; Boucher C; Zhao H; O'Connor AB; Roveto P; Bauer D; Graceffa R; Richards WG; Babij P
Bioorg Med Chem Lett; 2009 Sep; 19(17):4924-8. PubMed ID: 19648005
[TBL] [Abstract][Full Text] [Related]
2. Trifluoromethylpyrimidine-based inhibitors of proline-rich tyrosine kinase 2 (PYK2): structure-activity relationships and strategies for the elimination of reactive metabolite formation.
Walker DP; Bi FC; Kalgutkar AS; Bauman JN; Zhao SX; Soglia JR; Aspnes GE; Kung DW; Klug-McLeod J; Zawistoski MP; McGlynn MA; Oliver R; Dunn M; Li JC; Richter DT; Cooper BA; Kath JC; Hulford CA; Autry CL; Luzzio MJ; Ung EJ; Roberts WG; Bonnette PC; Buckbinder L; Mistry A; Griffor MC; Han S; Guzman-Perez A
Bioorg Med Chem Lett; 2008 Dec; 18(23):6071-7. PubMed ID: 18951788
[TBL] [Abstract][Full Text] [Related]
3. Antitumor activity and pharmacology of a selective focal adhesion kinase inhibitor, PF-562,271.
Roberts WG; Ung E; Whalen P; Cooper B; Hulford C; Autry C; Richter D; Emerson E; Lin J; Kath J; Coleman K; Yao L; Martinez-Alsina L; Lorenzen M; Berliner M; Luzzio M; Patel N; Schmitt E; LaGreca S; Jani J; Wessel M; Marr E; Griffor M; Vajdos F
Cancer Res; 2008 Mar; 68(6):1935-44. PubMed ID: 18339875
[TBL] [Abstract][Full Text] [Related]
4. An in silico high-throughput screen identifies potential selective inhibitors for the non-receptor tyrosine kinase Pyk2.
Meirson T; Samson AO; Gil-Henn H
Drug Des Devel Ther; 2017; 11():1535-1557. PubMed ID: 28572720
[TBL] [Abstract][Full Text] [Related]
5. Identification of novel series of pyrazole and indole-urea based DFG-out PYK2 inhibitors.
Bhattacharya SK; Aspnes GE; Bagley SW; Boehm M; Brosius AD; Buckbinder L; Chang JS; Dibrino J; Eng H; Frederick KS; Griffith DA; Griffor MC; Guimarães CR; Guzman-Perez A; Han S; Kalgutkar AS; Klug-McLeod J; Garcia-Irizarry C; Li J; Lippa B; Price DA; Southers JA; Walker DP; Wei L; Xiao J; Zawistoski MP; Zhao X
Bioorg Med Chem Lett; 2012 Dec; 22(24):7523-9. PubMed ID: 23153798
[TBL] [Abstract][Full Text] [Related]
6. Protein-tyrosine kinase CAKbeta/PYK2 is activated by binding Ca2+/calmodulin to FERM F2 alpha2 helix and thus forming its dimer.
Kohno T; Matsuda E; Sasaki H; Sasaki T
Biochem J; 2008 Mar; 410(3):513-23. PubMed ID: 18031286
[TBL] [Abstract][Full Text] [Related]
7. Small molecules with potent osteogenic-inducing activity in osteoblast cells.
Han CY; Wang Y; Yu L; Powers D; Xiong X; Yu V; Nguyen Y; Jean DJ; Babij P
Bioorg Med Chem Lett; 2009 Mar; 19(5):1442-5. PubMed ID: 19179072
[TBL] [Abstract][Full Text] [Related]
8. Calcineurin is essential for depolarization-induced nuclear translocation and tyrosine phosphorylation of PYK2 in neurons.
Faure C; Corvol JC; Toutant M; Valjent E; Hvalby O; Jensen V; El Messari S; Corsi JM; Kadaré G; Girault JA
J Cell Sci; 2007 Sep; 120(Pt 17):3034-44. PubMed ID: 17684059
[TBL] [Abstract][Full Text] [Related]
9. Discovery and structure-activity relationship of 3-aminopyrid-2-ones as potent and selective interleukin-2 inducible T-cell kinase (Itk) inhibitors.
Charrier JD; Miller A; Kay DP; Brenchley G; Twin HC; Collier PN; Ramaya S; Keily SB; Durrant SJ; Knegtel RM; Tanner AJ; Brown K; Curnock AP; Jimenez JM
J Med Chem; 2011 Apr; 54(7):2341-50. PubMed ID: 21391610
[TBL] [Abstract][Full Text] [Related]
10. FAK and PYK2 interact with SAP90/PSD-95-Associated Protein-3.
Bongiorno-Borbone L; Kadaré G; Benfenati F; Girault JA
Biochem Biophys Res Commun; 2005 Nov; 337(2):641-6. PubMed ID: 16202977
[TBL] [Abstract][Full Text] [Related]
11. Crystal structures of free and ligand-bound focal adhesion targeting domain of Pyk2.
Lulo J; Yuzawa S; Schlessinger J
Biochem Biophys Res Commun; 2009 Jun; 383(3):347-52. PubMed ID: 19358827
[TBL] [Abstract][Full Text] [Related]
12. Discovery of aryl aminoquinazoline pyridones as potent, selective, and orally efficacious inhibitors of receptor tyrosine kinase c-Kit.
Hu E; Tasker A; White RD; Kunz RK; Human J; Chen N; Bürli R; Hungate R; Novak P; Itano A; Zhang X; Yu V; Nguyen Y; Tudor Y; Plant M; Flynn S; Xu Y; Meagher KL; Whittington DA; Ng GY
J Med Chem; 2008 Jun; 51(11):3065-8. PubMed ID: 18447379
[TBL] [Abstract][Full Text] [Related]
13. Selectivity switch between FAK and Pyk2: Macrocyclization of FAK inhibitors improves Pyk2 potency.
Farand J; Mai N; Chandrasekhar J; Newby ZE; Van Veldhuizen J; Loyer-Drew J; Venkataramani C; Guerrero J; Kwok A; Li N; Zherebina Y; Wilbert S; Zablocki J; Phillips G; Watkins WJ; Mourey R; Notte GT
Bioorg Med Chem Lett; 2016 Dec; 26(24):5926-5930. PubMed ID: 27876318
[TBL] [Abstract][Full Text] [Related]
14. Induction of proline-rich tyrosine kinase2 (Pyk2) through C/EBPbeta is involved in PMA-induced monocyte differentiation.
Park MH; Park SY; Kim Y
FEBS Lett; 2008 Feb; 582(3):415-22. PubMed ID: 18198130
[TBL] [Abstract][Full Text] [Related]
15. 6-amino-4-(pyrimidin-4-yl)pyridones: novel glycogen synthase kinase-3β inhibitors.
Coffman K; Brodney M; Cook J; Lanyon L; Pandit J; Sakya S; Schachter J; Tseng-Lovering E; Wessel M
Bioorg Med Chem Lett; 2011 Mar; 21(5):1429-33. PubMed ID: 21295469
[TBL] [Abstract][Full Text] [Related]
16. 4-(Benzimidazol-2-yl)-1,2,5-oxadiazol-3-ylamine derivatives: potent and selective p70S6 kinase inhibitors.
Bandarage U; Hare B; Parsons J; Pham L; Marhefka C; Bemis G; Tang Q; Moody CS; Rodems S; Shah S; Adams C; Bravo J; Charonnet E; Savic V; Come JH; Green J
Bioorg Med Chem Lett; 2009 Sep; 19(17):5191-4. PubMed ID: 19632115
[TBL] [Abstract][Full Text] [Related]
17. Benzothiophene inhibitors of MK2. Part 1: structure-activity relationships, assessments of selectivity and cellular potency.
Anderson DR; Meyers MJ; Kurumbail RG; Caspers N; Poda GI; Long SA; Pierce BS; Mahoney MW; Mourey RJ
Bioorg Med Chem Lett; 2009 Aug; 19(16):4878-81. PubMed ID: 19616945
[TBL] [Abstract][Full Text] [Related]
18. 4-Anilino-7-alkenylquinoline-3-carbonitriles as potent MEK1 kinase inhibitors.
Berger DM; Dutia M; Powell D; Floyd MB; Torres N; Mallon R; Wojciechowicz D; Kim S; Feldberg L; Collins K; Chaudhary I
Bioorg Med Chem; 2008 Oct; 16(20):9202-11. PubMed ID: 18815050
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological Inhibition of FAK-Pyk2 Pathway Protects Against Organ Damage and Prolongs the Survival of Septic Mice.
Alves GF; Aimaretti E; Einaudi G; Mastrocola R; de Oliveira JG; Collotta D; Porchietto E; Aragno M; Cifani C; Sordi R; Thiemermann C; Fernandes D; Collino M
Front Immunol; 2022; 13():837180. PubMed ID: 35178052
[TBL] [Abstract][Full Text] [Related]
20. Kinase inhibitor data modeling and de novo inhibitor design with fragment approaches.
Vieth M; Erickson J; Wang J; Webster Y; Mader M; Higgs R; Watson I
J Med Chem; 2009 Oct; 52(20):6456-66. PubMed ID: 19791746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
